BUCCOLAM
NEURAXPHARM PHARMACEUTICALS, S.L.
Quick answers
Is there a shortage of BUCCOLAM in Canada?
No. There is no current shortage of BUCCOLAM 2.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
MIDAZOLAM INJECTION
NOVOPHARM LIMITED
MIDAZOLAM INJECTION BP
HOSPIRA HEALTHCARE ULC
BUCCOLAM
NEURAXPHARM PHARMACEUTICALS, S.L.
VERSED INJ 1MG/ML
HOFFMANN-LA ROCHE LIMITED
VERSED INJ 5MG/ML
HOFFMANN-LA ROCHE LIMITED
APO-MIDAZOLAM INJECTABLE 5 MG/ML
APOTEX INC
DIN
02559579
Strength
2.5MG
Dosage Form
Solution
Route
Buccal
Active Ingredient
MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)
See all MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NEURAXPHARM PHARMACEUTICALS, S.L.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.